Boehringer’s Aptivus Approved For HIV In Kids
This article was originally published in The Pink Sheet Daily
Executive Summary
New oral solution gets approval for adults, too.
You may also be interested in...
Lilly Prasugrel Delay Could Extend Well Into 2009
FDA is looking at a February advisory committee for Lilly/Daiichi anti-clotting drug. Safety issues are one potential topic.
Lilly Prasugrel Delay Could Extend Well Into 2009
FDA is looking at a February advisory committee for Lilly/Daiichi anti-clotting drug. Safety issues are one potential topic.
Boehringer Ingelheim’s HIV Therapy Aptivus Gets Full FDA Approval
Protease inhibitor received accelerated approval in June 2005, but FDA requested additional post-marketing trials.